Showing 1 - 19 results of 19 for search 'van Lammeren, S', query time: 0.05s
Refine Results
-
1
Geomatics in physiognomic landscape research by Ron van Lammeren
Published 2011-09-01
Article -
2
Justin Roberts, Slavery and the Enlightenment in the British Atlantic, 1750-1807 by Dennis van Lammeren
Published 2014-09-01
Article -
3
Justin Roberts, Slavery and the Enlightenment in the British Atlantic, 1750-1807 by Dennis van Lammeren
Published 2014-09-01
Article -
4
-
5
Missing migrants and their families: a call for greater international cooperation by van Lammeren, S, von König, F
Published 2021Journal article -
6
Exploring visual landscapes by Steffen Nijhuis, Ron van Lammeren, Marc Antrop
Published 2011-09-01
Article -
7
Sensing Landscape History with an Interactive Location Based Service by Paul Roncken, Martin Goossen, Ron van Lammeren
Published 2009-09-01
Article -
8
-
9
Combination of ground-based and satellite cloud observations on a routine basis by André van Lammeren, Arnoud Feijt, Joop Konings, Erik van Meijgaard, Aad van Ulden
Published 2000-07-01
Article -
10
-
11
-
12
-
13
Histological features of carotid plaque in patients with ocular ischemia versus cerebral events. by Howard, D, van Lammeren, G, Redgrave, J, Moll, F, de Vries, J, de Kleijn, D, de Borst, G, Pasterkamp, G, Rothwell, P
Published 2013Journal article -
14
Histological features of carotid plaque in patients with ocular ischaemia versus cerebral events by Howard, D, van Lammeren, G, Redgrave, J, Moll, F, de Vries, J, de Kleijn, D, de Borst, G, Pasterkamp, G, Rothwell, P
Published 2013Conference item -
15
Risk factors for graft-versus-host-disease after donor lymphocyte infusion following T-cell depleted allogeneic stem cell transplantation by Eva A. S. Koster, Peter A. von dem Borne, Peter van Balen, Erik W. A. Marijt, Jennifer M. L. Tjon, Tjeerd J. F. Snijders, Daniëlle van Lammeren, Hendrik Veelken, J. H. Frederik Falkenburg, Constantijn J. M. Halkes, Liesbeth C. de Wreede
Published 2024-03-01
Article -
16
Joint models quantify associations between immune cell kinetics and allo-immunological events after allogeneic stem cell transplantation and subsequent donor lymphocyte infusion by Eva A. S. Koster, Edouard F. Bonneville, Peter A. von dem Borne, Peter van Balen, Erik W. A. Marijt, Jennifer M. L. Tjon, Tjeerd J. F. Snijders, Daniëlle van Lammeren, Hendrik Veelken, Hein Putter, J. H. Frederik Falkenburg, Constantijn J. M. Halkes, Liesbeth C. de Wreede
Published 2023-08-01
Article -
17
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP,... by M. Lübbert, P. Wijermans, M. Kicinski, S. Chantepie, W. van der Velden, R. Noppeney, L. Griskevicius, A. Neubauer, M. Crysandt, R. Vrhovac, M. Luppi, S. Fuhrmann, E. Audisio, A. Candoni, O. Legrand, R. Foà, G. Gaidano, D. van Lammeren-Venema, E. F. Posthuma, M. Hoogendoorn, A. Giraut, M. Stevens-Kroef, J. H. Jansen, E. Ammatuna, J.-P. Vilque, R. Wäsch, H. Becker, N. Blijlevens, U. Dührsen, F. Baron, S. Suciu, S. Amadori, A. Venditti, G. Huls
Published 2022-06-01
Article -
18
Age and sex associate with outcome in older AML and high risk MDS patients treated with 10-day decitabine by Jacobien R. Hilberink, Isabelle A. van Zeventer, Dana A. Chitu, Thomas Pabst, Saskia K. Klein, Georg Stussi, Laimonas Griskevicius, Peter J. M. Valk, Jacqueline Cloos, Arjan A. van de Loosdrecht, Dimitri Breems, Danielle van Lammeren-Venema, Rinske Boersma, Mojca Jongen-Lavrencic, Martin Fehr, Mels Hoogendoorn, Markus G. Manz, Maaike Söhne, Rien van Marwijk Kooy, Dries Deeren, Marjolein W. M. van der Poel, Marie Cecile Legdeur, Lidwine Tick, Yves Chalandon, Emanuele Ammatuna, Sabine Blum, Bob Löwenberg, Gert J. Ossenkoppele, Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON), Swiss Group for Clinical Cancer Research (SAKK), Gerwin Huls
Published 2023-06-01
Article -
19
Inferior Outcome of Addition of the Aminopeptidase Inhibitor Tosedostat to Standard Intensive Treatment for Elderly Patients with AML and High Risk MDS by Jeroen Janssen, Bob Löwenberg, Markus Manz, Mario Bargetzi, Bart Biemond, Peter von dem Borne, Dimitri Breems, Rolf Brouwer, Yves Chalandon, Dries Deeren, Anna Efthymiou, Bjørn-Tore Gjertsen, Carlos Graux, Michael Gregor, Dominik Heim, Urs Hess, Mels Hoogendoorn, Aurelie Jaspers, Asiong Jie, Mojca Jongen-Lavrencic, Saskia Klein, Marjolein van der Klift, Jürgen Kuball, Danielle van Lammeren-Venema, Marie-Cecile Legdeur, Arjan van de Loosdrecht, Johan Maertens, Marinus van Marwijk Kooy, Ine Moors, Marten Nijziel, Florence van Obbergh, Margriet Oosterveld, Thomas Pabst, Marjolein van der Poel, Harm Sinnige, Olivier Spertini, Wim Terpstra, Lidwine Tick, Walter van der Velden, Marie-Christiane Vekemans, Edo Vellenga, Okke de Weerdt, Peter Westerweel, Georg Stüssi, Yvette van Norden, Gert Ossenkoppele
Published 2021-02-01
Article